Update on Atopic Dermatitis

Caitlyn Kellogg; Jan Smogorzewski

doi:10.1016/j.yapd.2023.03.006

Update on Atopic Dermatitis

Adv Pediatr. 2023 Aug;70(1):157-170. doi: 10.1016/j.yapd.2023.03.006. Epub 2023 May 5.

Authors

Caitlyn Kellogg¹, Jan Smogorzewski²

Affiliations

¹ Department of Internal Medicine, Harbor-UCLA, 1000 West Carson Street, Box 458, Torrance, CA 90509, USA.
² Department of Internal Medicine, Division of Dermatology, Harbor-UCLA, 1000 West Carson Street, Box 458, Torrance, CA 90502, USA. Electronic address: JSmogorzewski@dhs.lacounty.gov.

PMID: 37422293
DOI: 10.1016/j.yapd.2023.03.006

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disorder with a lifetime prevalence of up to 20% which can occur at any age but is most common among children. There is a significant burden of pediatric AD in the primary care setting; thus, the ability to recognize and manage AD is of utmost importance to pediatricians. Treatment of AD requires a multifaceted approach based on a patient's severity including behavioral modifications, topical and systemic pharmacologic therapies, and phototherapy.

Keywords: Atopic dermatitis; Biologics; Pediatric; Phototherapy; Topicals.

Publication types

Review

MeSH terms

Behavior Therapy
Child
Dermatitis, Atopic* / diagnosis
Dermatitis, Atopic* / epidemiology
Dermatitis, Atopic* / therapy
Humans
Phototherapy